Regeneron Pharmaceuticals (REGN) Earnings Date, Estimates & Call Transcripts

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free regn Stock Alerts

$893.99

-7.20 (-0.80%)

(As of 04/18/2024 ET)

Compare

Upcoming Earnings Date: May. 2
Before Market Opens
Confirmed
Actual EPS (Feb. 2): $11.86 Beat By $1.13
Consensus EPS (Feb. 2): $10.73

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

REGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

REGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Regeneron Pharmaceuticals Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	$7.48	$8.05	$7.77
Q2 2024	2	$9.59	$9.67	$9.63
Q3 2024	2	$9.80	$11.42	$10.61
Q4 2024	2	$7.72	$10.57	$9.15
FY 2024	8	$34.59	$39.71	$37.15

REGN Earnings Date and Information

Regeneron Pharmaceuticals last released its earnings data on February 2nd, 2024. The biopharmaceutical company reported $11.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.73 by $1.13. The firm earned $3.43 billion during the quarter, compared to analysts' expectations of $3.29 billion. Its quarterly revenue was up .6% compared to the same quarter last year. Regeneron Pharmaceuticals has generated $34.75 earnings per share over the last year ($34.75 diluted earnings per share) and currently has a price-to-earnings ratio of 25.7. Earnings for Regeneron Pharmaceuticals are expected to grow by 4.04% in the coming year, from $38.58 to $40.14 per share. Regeneron Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Regeneron Pharmaceuticals will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Regeneron Pharmaceuticals Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/2/2024 Confirmed)	-	-	-	-	-	-	-
2/2/2024	Q4 2023	$10.73	$11.86	+$1.13	$10.17	$3.29 billion	$3.43 billion
11/2/2023	Q3 2023	$9.39	$10.17	+$0.78	$11.45	$3.23 billion	$3.36 billion
8/3/2023	Q2 2023	$8.48	$10.24	+$1.76	$9.08	$3.02 billion	$3.16 billion
5/4/2023	Q1 2023	$7.71	$8.44	+$0.73	$9.71	$2.92 billion	$3.16 billion
2/3/2023	Q4 2022	$8.18	$12.56	+$4.38	$11.42	$3.11 billion	$3.41 billion
11/3/2022	Q3 2022	$8.55	$9.98	+$1.43	$8.30	$2.79 billion	$2.94 billion
Get the Latest News and Ratings for REGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
8/3/2022	Q2 2022	$8.53	$9.77	+$1.24	$12.07	$2.80 billion	$2.86 billion
5/4/2022	Q1 2022	$9.37	$11.49	+$2.12	$14.37	$2.69 billion	$2.97 billion
2/4/2022	Q4 2021	$18.49	$23.72	+$5.23	$27.75	$4.49 billion	$4.95 billion
11/4/2021	Q3 2021	$9.81	$15.37	+$5.56	$16.41	$2.80 billion	$3.45 billion
8/5/2021	Q2 2021	$8.81	$25.80	+$16.99	$27.97	$3.90 billion	$5.14 billion
5/6/2021	Q1 2021	$7.78	$9.89	+$2.11	$10.09	$2.69 billion	$2.53 billion

Regeneron Pharmaceuticals Earnings - Frequently Asked Questions

When is Regeneron Pharmaceuticals's earnings date?: Regeneron Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on REGN's earnings history.
Did Regeneron Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) reported $11.86 earnings per share (EPS) to beat the analysts' consensus estimate of $10.73 by $1.13. Learn more on analysts' earnings estimate vs. REGN's actual earnings.
How can I listen to Regeneron Pharmaceuticals's earnings conference call?: The conference call for Regeneron Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call
How can I read Regeneron Pharmaceuticals's conference call transcript?: The conference call transcript for Regeneron Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Regeneron Pharmaceuticals generate each year?: Regeneron Pharmaceuticals (NASDAQ:REGN) has a recorded annual revenue of $13.12 billion.
How much profit does Regeneron Pharmaceuticals generate each year?: Regeneron Pharmaceuticals (NASDAQ:REGN) has a recorded net income of $3.95 billion. REGN has generated $34.75 earnings per share over the last four quarters.
What is Regeneron Pharmaceuticals's price-to-earnings ratio?: Regeneron Pharmaceuticals (NASDAQ:REGN) has a trailing price-to-earnings ratio of 25.73 and a forward price-to-earnings ratio of 23.17. The price/earnings-to-growth ratio is 2.58.
What is Regeneron Pharmaceuticals's EPS forecast for next year?: Regeneron Pharmaceuticals's earnings are expected to grow from $38.58 per share to $40.14 per share in the next year, which is a 4.04% increase.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:REGN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Regeneron Pharmaceuticals (REGN) Earnings Date, Estimates & Call Transcripts

REGN Earnings Estimates and Actuals by Quarter

REGN Estimated and Actual Revenue by Quarter

Regeneron Pharmaceuticals Analyst EPS Estimates

REGN Earnings Date and Information

Regeneron Pharmaceuticals Earnings History by Quarter

Regeneron Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Regeneron Pharmaceuticals (REGN) Earnings Date, Estimates & Call Transcripts

Earnings Summary

REGN Earnings Estimates and Actuals by Quarter

REGN Estimated and Actual Revenue by Quarter

Regeneron Pharmaceuticals Analyst EPS Estimates

REGN Earnings Date and Information

Regeneron Pharmaceuticals Earnings History by Quarter

Regeneron Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat